Related Experiment Video
Updated: Mar 25, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
TRIMming p53's anticancer activity
S Elabd1,2, G Meroni3, C Blattner1
1Institute of Toxicology and Genetics, Karlsruhe Institute of Technology, Karlsruhe, Germany.
Abstract:
Several TRIM proteins control abundance and activity of p53. Along this route, TRIM proteins have a serious impact on carcinogenesis and prognosis for cancer patients. In the past years, a significant increase has been made in our understanding of how the TRIM protein family controls p53 activity.
Insights
Tripartite motif (TRIM) proteins regulate the tumor suppressor p53, impacting cancer development and patient outcomes. Understanding TRIM-p53 interactions is crucial for cancer research and therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- The tumor suppressor p53 is a critical regulator of cellular responses to stress.
- Dysregulation of p53 is implicated in numerous human cancers.
- Tripartite motif (TRIM) proteins are a diverse family of proteins involved in various cellular processes.
Purpose of the Study:
- To elucidate the mechanisms by which TRIM proteins influence p53 abundance and activity.
- To understand the role of TRIM-p53 interactions in carcinogenesis.
- To explore the implications of TRIM proteins for cancer prognosis.
Main Methods:
- The study likely involved molecular biology techniques to assess protein-protein interactions.
- Western blotting or similar methods were probably used to quantify protein levels.
- Functional assays may have been employed to evaluate p53 activity.
Main Results:
- Evidence suggests that specific TRIM proteins directly control the stability and/or activity of p53.
- These regulatory interactions have significant consequences for cellular transformation.
- The findings highlight TRIM proteins as key players in the p53 pathway.
Conclusions:
- TRIM proteins are important modulators of p53 function.
- Targeting TRIM-p53 interactions may offer novel therapeutic strategies for cancer treatment.
- Further research into the TRIM protein family is warranted for cancer prognosis and therapy.
More Related Videos
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
09:32Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway
Inhibition of Cdk Activity